SLC23A2 and breast carcinoma: Interestingly, SVCT2 expression was absent or weak in normal tissues but strongly detected in tumor samples obtained from breast cancer patients, suggesting that functional SVCT2 sensitizes breast cancer cells to autophagic damage by increasing the ascorbate concentration and intracellular ROS production.